Hiroyuki Sakashita

Yokosuka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B).

Comparison of anthracycline plus platinum versus other platinum-based regimens as first-line chemotherapy for untreated thymoma: A retrospective cohort study (NEJ023B).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: January 29, 2026

Real-world comparative effectiveness of atezolizumab versus durvalumab for extensive-stage small-cell lung cancer.

Real-world comparative effectiveness of atezolizumab versus durvalumab for extensive-stage small-cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 15, 2025

A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.

A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence.

Journal: JAMA oncology

Published: November 30, 2023

High density and proximity of CD8+ T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma.

High density and proximity of CD8+ T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma.

Journal: Thoracic cancer

Published: April 18, 2023

Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.

Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.

Journal: JTO clinical and research reports

Published: August 11, 2022

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).

Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 06, 2022

A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).

A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114).

Journal: Thoracic cancer

Published: December 13, 2021

Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases.

Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases.

Journal: Thoracic cancer

Published: July 07, 2021

Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease.

Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 23, 2020

Autoimmune Hepatitis in Small Cell Lung Cancer-A Case Report

Autoimmune Hepatitis in Small Cell Lung Cancer-A Case Report

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: June 17, 2020

Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.

Notable response to nivolumab during the treatment of SMARCA4-deficient thoracic sarcoma: a case report.

Journal: Immunotherapy

Published: May 05, 2020

Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)

Clinical Utility of Comprehensive Genome Profiling Using FoundationOne CDx in Japanese Population(PROFILE-F Study)

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: November 22, 2019

Showing 1-12 of 33

Last Updated: 09/26/2026